(Health-NewsWire.Net, May 12, 2017 ) According to the report “Asia-Pacific Antivenom Market”, published by Market Data Forecast, the market is estimated to be steadily growing with a CAGR of 8.59% to reach USD 325.7 million by 2021, from USD 215.7 million in 2016.
Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. It is used to detoxify animal bites that are poisonous. Treatment with specific antivenoms is considered the only cure. Venomous bites cause certain condition like excessive saliva, muscle weakness, breathing problem and other problems. Some venomous bites may cause deaths also.
It is estimated that around 40,000 to 80,000 people die in Asia due to animal bites. Most of these deaths occur in India. To overcome poisonous effects after venomous bites, manufacturers developed number of Antivenom products including vaccines and hyper immune sera.
The report also presents detailed analysis of multitude of drivers and restraints affecting the antivenom market bearing either positive or negative outcomes. Some of those factors are
• Increasing cases of Snake bites.
• Demand of effective antivenom products.
• Increasing investment in R&D to develop new antivenoms.
For Full Report refer to: http://www.marketdataforecast.com/market-reports/asia-pacific-antivenom-market-1583/
For detailed understanding Antivenom market is differentiated on basis of type and animals. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Asia-Pacific Market for Antivenom is broadly categorized into type and animal. On the basis of type, Asia-Pacific Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others.
Free Sample for report: http://www.marketdataforecast.com/market-reports/asia-pacific-antivenom-market-1583/request-sample
Geographically, Asia-Pacific Antivenom market is segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is the fastest growing region with highest cumulative growth.
Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc. (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India). Myanmar is taking a lead in exporting antivenom products to neighboring c countries in Asia.
Buy now at: https://www.marketdataforecast.com/cart/buy-now/asia-pacific-antivenom-market-1583
The Asia-Pacific Antivenom market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of type and animals along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.
Enquire about the report: http://www.marketdataforecast.com/market-reports/asia-pacific-antivenom-market-1583/inquire
Checkout other related studies in the Pharmaceuticals Segment:
Anti-Aging Market by Demographics: http://www.marketdataforecast.com/market-reports/global-anti-aging-market-1398/
Anti-coccidian Drugs Market: http://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market-13/
Antifungal Drugs Market: http://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: http://www.marketdataforecast.com/market-reports/global-attention-deficit-hyperactivity-disorder-therapeutics-market-304/
Bio Pharmaceuticals Market: http://www.marketdataforecast.com/market-reports/global-bio-pharmaceuticals-market-633/
About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact:
Abhishek Shukla
Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|